HCW BIOLOGICS INC. - COMMON STOCK

HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic

24 أغسطس 2021 06:32:00 بحسب Nasdaq GlobeNewswire

HCW Biologics’ Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein (TOBI™) Discovery Platform

17 أغسطس 2021 06:32:00 بحسب Nasdaq GlobeNewswire

HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights

13 أغسطس 2021 06:10:00 بحسب Nasdaq GlobeNewswire

HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering

22 يوليو 2021 15:05:00 بحسب Nasdaq GlobeNewswire

HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering

19 يوليو 2021 17:39:57 بحسب Nasdaq GlobeNewswire